Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Liabilities (2016 - 2026)

Veracyte's Total Liabilities history spans 14 years, with the latest figure at $96.4 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 22.27% to $96.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $96.4 million, a 22.27% decrease, with the full-year FY2025 number at $96.4 million, down 22.27% from a year prior.
  • Total Liabilities hit $96.4 million in Q4 2025 for Veracyte, down from $110.1 million in the prior quarter.
  • Over the last five years, Total Liabilities for VCYT hit a ceiling of $124.1 million in Q4 2024 and a floor of $50.9 million in Q1 2021.
  • Historically, Total Liabilities has averaged $87.9 million across 5 years, with a median of $81.3 million in 2022.
  • Biggest five-year swings in Total Liabilities: surged 154.13% in 2021 and later decreased 22.27% in 2025.
  • Tracing VCYT's Total Liabilities over 5 years: stood at $91.3 million in 2021, then fell by 11.05% to $81.2 million in 2022, then dropped by 12.83% to $70.8 million in 2023, then soared by 75.23% to $124.1 million in 2024, then dropped by 22.27% to $96.4 million in 2025.
  • Business Quant data shows Total Liabilities for VCYT at $96.4 million in Q4 2025, $110.1 million in Q3 2025, and $123.0 million in Q2 2025.